Upstream Bio, Inc.
UPB
$5.78
-$0.41-6.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 773.00K | 1.03M | 668.00K | 683.00K | 937.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 773.00K | 1.03M | 668.00K | 683.00K | 937.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 773.00K | 1.03M | 668.00K | 683.00K | 937.00K |
| SG&A Expenses | 7.05M | 8.08M | 6.67M | 5.54M | 7.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.14M | 44.65M | 46.84M | 38.52M | 45.28M |
| Operating Income | -42.37M | -43.62M | -46.17M | -37.83M | -44.35M |
| Income Before Tax | -39.70M | -40.59M | -42.46M | -33.75M | -39.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.70M | -40.59M | -42.46M | -33.75M | -39.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.70M | -40.59M | -42.46M | -33.75M | -39.97M |
| EBIT | -42.37M | -43.62M | -46.17M | -37.83M | -44.35M |
| EBITDA | -42.32M | -43.57M | -46.11M | -37.79M | -44.31M |
| EPS Basic | -0.73 | -0.75 | -0.79 | -0.63 | -0.74 |
| Normalized Basic EPS | -0.45 | -0.47 | -0.49 | -0.39 | -0.46 |
| EPS Diluted | -0.73 | -0.75 | -0.79 | -0.63 | -0.74 |
| Normalized Diluted EPS | -0.45 | -0.47 | -0.49 | -0.39 | -0.46 |
| Average Basic Shares Outstanding | 54.57M | 54.33M | 54.09M | 53.93M | 53.77M |
| Average Diluted Shares Outstanding | 54.57M | 54.33M | 54.09M | 53.93M | 53.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |